<img alt="" height="1" width="1" />
A.P. says FDA asks more about drug, shares halved
BusinessWeek
The Food and Drug Administration delayed approval of an AP Pharma Inc. drug intended to treat nausea and vomiting caused by chemotherapy, the company said Friday. The agency asked for three new studies, and AP Pharma does not expect to be able to ...
A.P. Pharma sinks; Medicines Co. gainsMarketWatch
FDA denies approval of AP Pharma nausea drug; shrs sinkReuters
FDA turns back AP Pharma nausea drugMSN Money
ONN.tv -RTT News -TheStreet.com
all 58 news articles »
More...